These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. AGGLUTINABILITY OF RED CELLS BY ANTI-I IN PATIENTS WITH THALASSEMIA MAJOR AND OTHER HAEMATOLOGICAL DISORDERS. GIBLETT ER; CROOKSTON MC Nature; 1964 Mar; 201():1138-9. PubMed ID: 14152804 [No Abstract] [Full Text] [Related]
8. [Paroxysmal nocturnal hemoglobinuria: An unknown cause of thrombosis?]. Doutrelon C; Skopinski S; Boulon C; Constans J; Viallard JF; Peffault de Latour R J Mal Vasc; 2015 Dec; 40(6):384-90. PubMed ID: 26205796 [TBL] [Abstract][Full Text] [Related]
9. A closer look at paroxysmal nocturnal hemoglobinuria. Rachidi S; Musallam KM; Taher AT Eur J Intern Med; 2010 Aug; 21(4):260-7. PubMed ID: 20603032 [TBL] [Abstract][Full Text] [Related]
10. The differential diagnosis of hemolytic anemias. Costea N Med Clin North Am; 1973 Mar; 57(2):289-302. PubMed ID: 4570931 [No Abstract] [Full Text] [Related]
11. A chemically induced rat model of hemolysis with disseminated thrombosis. Ezov N; Levin-Harrus T; Mittelman M; Redlich M; Shabat S; Ward SM; Peddada S; Nyska M; Yedgar S; Nyska A Cardiovasc Toxicol; 2002; 2(3):181-94. PubMed ID: 12665664 [TBL] [Abstract][Full Text] [Related]
13. Hemolytic anemia, iron deficiency and personal history of deep vein thrombosis: consider paroxysmal nocturnal hemoglobinuria. Gendron N; Arlet JB; Gaussem P; Radford-Weiss I; Dupeux S; Rosain J; La Tour RP; Darnige L Ann Biol Clin (Paris); 2017 Oct; 75(5):580-588. PubMed ID: 28958970 [TBL] [Abstract][Full Text] [Related]
14. [STUDY OF THE SURVIVAL OF ERYTHROCYTES WITH THE CR-51 METHOD]. GIUSTINA G; FERRARIO G Rass Clin Sci; 1963 Jun; 39():172-84. PubMed ID: 14044522 [No Abstract] [Full Text] [Related]
15. Paroxysmal Nocturnal Hemoglobinuria is rare cause for thrombosis of the intra-abdominal veins in the ethnic Indian population - results from FLAER-based flowcytometry screening. Ahluwalia J; Naseem S; Sachdeva MU; Bose P; Bose SK; Kumar N; Thapa BR; Varma N; Chawla YK Eur J Haematol; 2014; 92(5):435-43. PubMed ID: 24400962 [TBL] [Abstract][Full Text] [Related]
16. Hemolytic anemias due to hemoglobinopathies. Poyart C; Wajcman H Mol Aspects Med; 1996 Apr; 17(2):129-42. PubMed ID: 8813715 [TBL] [Abstract][Full Text] [Related]
17. Hematopoietic cells from -spectrin-deficient mice are sufficient to induce thrombotic events in hematopoietically ablated recipients. Wandersee NJ; Lee JC; Kaysser TM; Bronson RT; Barker JE Blood; 1998 Dec; 92(12):4856-63. PubMed ID: 9845553 [TBL] [Abstract][Full Text] [Related]
18. Paroxysmal nocturnal hemoglobinuria and the risk of venous thrombosis: review and recommendations for management of the pregnant and nonpregnant patient. Ray JG; Burows RF; Ginsberg JS; Burrows EA Haemostasis; 2000; 30(3):103-17. PubMed ID: 11014960 [TBL] [Abstract][Full Text] [Related]
19. Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Yuan X; Gavriilaki E; Thanassi JA; Yang G; Baines AC; Podos SD; Huang Y; Huang M; Brodsky RA Haematologica; 2017 Mar; 102(3):466-475. PubMed ID: 27810992 [TBL] [Abstract][Full Text] [Related]
20. Clinical course and disease burden in patients with paroxysmal nocturnal hemoglobinuria by hemolytic status. Yenerel MN; Muus P; Wilson A; Szer J Blood Cells Mol Dis; 2017 Jun; 65():29-34. PubMed ID: 28437723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]